Verition Fund Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,170
| Closed | -$240K | – | 2388 |
|
|
2023
Q4 | $240K | Sell |
10,170
-527
| -5% | -$12.4K | ﹤0.01% | 1491 |
|
|
2023
Q3 | $159K | Buy |
+10,697
| New | +$159K | ﹤0.01% | 1684 |
|
|
2023
Q2 | – | Sell |
-100,342
| Closed | -$875K | – | 2353 |
|
|
2023
Q1 | $875K | Buy |
+100,342
| New | +$875K | 0.01% | 903 |
|
|
2022
Q4 | – | Sell |
-15,800
| Closed | -$55K | – | 2337 |
|
|
2022
Q3 | $55K | Hold |
15,800
| – | – | ﹤0.01% | 2077 |
|
|
2022
Q2 | $47K | Buy |
+15,800
| New | +$47K | ﹤0.01% | 2071 |
|
|
2020
Q3 | – | Sell |
-601,828
| Closed | -$2.1M | – | 1334 |
|
|
2020
Q2 | $2.1M | Buy |
+601,828
| New | +$2.1M | 0.07% | 180 |
|
|
2019
Q4 | – | Sell |
-280,614
| Closed | -$1.44M | – | 1265 |
|
|
2019
Q3 | $1.44M | Buy |
+280,614
| New | +$1.44M | 0.04% | 252 |
|
|
2018
Q2 | – | Sell |
-20,860
| Closed | -$271K | – | 1312 |
|
|
2018
Q1 | $271K | Buy |
+20,860
| New | +$271K | 0.02% | 826 |
|